Bulk lysis procedures alter target cell population counts.
bulk lysis
flow cytometry
measurable residual disease (MRD)
Journal
Cytometry. Part A : the journal of the International Society for Analytical Cytology
ISSN: 1552-4930
Titre abrégé: Cytometry A
Pays: United States
ID NLM: 101235694
Informations de publication
Date de publication:
09 May 2024
09 May 2024
Historique:
revised:
02
04
2024
received:
19
02
2024
accepted:
15
04
2024
medline:
9
5
2024
pubmed:
9
5
2024
entrez:
9
5
2024
Statut:
aheadofprint
Résumé
To achieve high-sensitivity cell measurements (<1 in 10
Identifiants
pubmed: 38722042
doi: 10.1002/cyto.a.24848
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Centres de Recerca de Catalunya
Organisme : 'la Caixa' Foundation
Organisme : Thermo Fisher Scientific
Informations de copyright
© 2024 International Society for Advancement of Cytometry.
Références
Donnenberg AD, Donnenberg VS. Rare‐event analysis in flow cytometry. Clin Lab Med. 2007;27:627–652.
Short NJ, Zhou S, Fu C, Berry DA, Walter RB, Freeman SD, et al. Association of Measurable Residual Disease with Survival Outcomes in patients with acute myeloid leukemia: a systematic review and meta‐analysis. JAMA Oncol. 2020;6(12):1890–1899.
Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, et al. 2021 update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party. Blood. 2021;138(26):2753–2767.
Chatterjee G, Dhende P, Raj S, Shetty V, Ghogale S, Deshpande N, et al. 15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: real‐world applicability and challenges. Eur J Haematol. 2023;112:122–136.
Kowarsch F, Maurer‐Granofszky M, Weijler L, Wödlinger M, Reiter M, Schumich A, et al. FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: an AIEOP‐BFM‐ALL‐FLOW study group report. Cytom Part A. 2023;105:24–35.
Flores‐Montero J, Sanoja‐Flores L, Paiva B, Puig N, García‐Sánchez O, Böttcher S, et al. Next generation flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017;31(10):2094–2103.
Theunissen P, Mejstrikova E, Sedek L, Van Der Sluijs‐Gelling AJ, Gaipa G, Bartels M, et al. Standardized flow cytometry for highly sensitive MRD measurements in B‐cell acute lymphoblastic leukemia. Blood. 2017;129(3):347–357.
EuroFlow Consortium. EuroFlow SOP for bulk lysis in MRD panels version 1.3 [Internet]. EuroFlow; 2018 [cited 2023 Oct 18]. Available from: https://euroflow.org/protocols/
Soh KT, Wallace PK. Monitoring of measurable residual disease in multiple myeloma by multiparametric flow cytometry. Curr Protoc Cytom. 2019;90(1):e63.
O'Donahue M, Johnson L. Lysing methods and reagents for flow cytometry immunophenotyping. ICCS; 2016 Dec 1.
Rico LG, Salvia R, Ward MD, Bradford JA, Petriz J. Flow‐cytometry‐based protocols for human blood/marrow immunophenotyping with minimal sample perturbation. STAR Protoc. 2021;2(4):100883.
Kantakamalakul W, Jaroenpool J, Pattanapanyasat K. A novel enhanced green fluorescent protein (EGFP)‐K562 flow cytometric method for measuring natural killer (NK) cell cytotoxic activity. J Immunol Methods. 2003;272(1–2):189–197.
Greve B, Beller C, Cassens U, Sibrowski W, Severin E, Göhde W. High‐grade loss of leukocytes and hematopoietic progenitor cells caused by erythrocyte‐lysing procedures for flow cytometric analyses. J Hematother Stem Cell Res. 2003;12(3):321–330.
Pan Q, Ye L, Deng Z, Li L, Liu H. Effects of red blood cell lysing solutions on the detection of peripheral basophils of healthy normals and sle patients by flow cytometry. J Immunoass Immunochem. 2014;35(4):368–377.
Rico LG, Salvia R, Juncà J, Ward MD, Bradford JA, Sorigué M, et al. Erythrocyte lysing solutions have a detrimental effect in flow cytometric dendritic cell detection. Cytometry A. 2022;103:383–391.
Rico LG, de la Calle FR, Salvia R, Ward MD, Bradford JA, Juncà J, et al. Impact of red blood cell lysing on rare event analysis. Cytometry A. 2022;103:335–346.